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Most people get Epstein-Barr virus (EBV) infection at young age and are asymptomatic. Pri-
mary EBV infection in adolescents and young adults however, often leads to infectious mononucleosis
(IM) with symptoms including fever, fatigue, and sore throat that can persist for months. Expansion
in the number of CD8+ T cells, especially against EBV lytic proteins, are the main cause of these
symptoms. We propose a mathematical model for the regulation of EBV infection within a host to
address the dependence of IM on age. This model tracks the number of virus, infected B cell and
epithelial cell, and CD8+ T-cell responses to the infection. We use this model to investigate three
hypotheses for the high incidence of IM in teenagers and young adults: saliva and antibody eﬀects
that increase with age, high cross-reactive T-cell responses, and a high initial viral load. The model
supports the ﬁrst two of these hypotheses, and suggests that variation in host antibody responses
and the complexity of the pre-existing cross-reactive T cell repertoire, both of which depend on age,
may play important roles in the etiology of IM.
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1 Introduction
Epstein-Barr virus (EBV) is a member of the herpesvirus family, infects over 90% of humans world-
wide and can persist for the lifetime of the person (Rickinson and Kieﬀ, 2001). EBV is transmitted
by intimate contact, mainly through saliva and oropharyngeal secretion (Andiman, 2006). Within a
host, the virus primarily targets two cell types, B cells and epithelial cells. EBV enters B cells and
epithelial cells through diﬀerent routes using diﬀerent glycoprotein complexes on its envelop (Hutt-
Fletcher, 2007). Host saliva and antibodies, like IgA and IgG, to viral glycoproteins can decrease the
infection of B cells but enhance the infection of epithelial cells (Sixbey and Yao, 1992; Turk et al.,
2006).
EBV can establish long-term infections in B cells, driving an infected B cell through stages
of latent infection where the viral genome remains inside the cell. The virus stays quiescent and
remains invisible to the immune response within memory B cells. These latently infected memory
B cells can be activated, becoming plasma-like B cells within which virions replicate and burst out
(lytic infection). Infection of epithelial cells typically results in lytic replication with viruses bursting
out and cell death (Hutt-Fletcher, 2005). Infections of both cell types are important, as in vitro
experiment shows that virus produced from one cell type preferentially infects the other (Borza and
Hutt-Fletcher, 2002).
Most people get EBV infection at young age and are asymptomatic. Adolescents and young
adults infected with EBV develop infectious mononucleosis in up to 50% of cases, with symptoms
including fever, fatigue, and sore throat that can persist for months (Andiman, 2006; Cohen, 2005).
These symptoms are caused mainly by expansion in the number of CD8+ T cells, especially against
EBV lytic proteins expressed during lytic replication and production of virions (Hislop et al., 2007).
In our previous work, we developed a mathematical model of the within-host dynamics to study
EBV long term infection and viral evolution (Huynh and Adler, 2010). In this study, we extend the
within-host model to include features of immune system thought to be important in IM: the role
of antibodies in shifting infections between the two cell types and the eﬀect of speciﬁc and cross-
reactive T-cell responses. The model tracks the number of viruses, infected B cells and epithelial
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We use this model to investigate the following three hypotheses.
• Saliva and antibody eﬀects
Host saliva and antibodies to EBV proteins promote infection of epithelial cells which, in turn,
can induce an elevated CD8+ T-cell response against lytic infection. This hypothesis comes
from observations that some unknown factor in host saliva and antibodies to viral proteins
have been observed to enhance epithelial cell infection, and that salivary IgA level increases
with age (Jafarzadeh et al., 2008; Sixbey and Yao, 1992; Turk et al., 2006; Weber-Mzell et al.,
2004).
• Cross-reactive T-cell responses
The complexity of the pre-existing memory T-cell repertoire may change with age. Adolescents
infected with EBV may recruit large numbers of cross-reactive memory T cells previously
created in response to other viral infections. These cross-reactive T-cell responses may be
more quickly activated, but less eﬃcient in controlling the infection than primary responses
from naive T cells (Clute et al., 2005; Rickinson and Kieﬀ, 1996).
• The initial viral load
High viral challenges in adolescents, often acquired via kissing, may induce aggressive CD8+
T-cell response (Hislop et al., 2007).
2 Model
Addressing the three hypotheses for the causes of IM requires consideration of antibody eﬀects
and state variables representing cross-reactive T-cell responses to latent and lytic infection. Our
mathematical model (Figure 1 and Equation 2.1) tracks two types of target cells, B cells and epithelial
cells, both B-cell derived (VB) and epithelial-cell derived (VE) viruses, two types of speciﬁc cytotoxic
T cells (CTLs) attacking latently infected B cells (T2) and lytically infected cells (T4), respectively,
and two types of cross-reacting CTLs against latently (T2c) and lytically (T4c) infected cells. B cells
is classiﬁed further into four state variables: naive B cells (B1), latently infected B cells (B2), latently
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not ordinarily harbor latent infection and require only two state variables: uninfected epithelial cells
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Figure 1: Model of EBV infection of B cells and epithelial cells. Antibodies like IgA can shift the
viral target from B cells to epithelial cells. Activation of cross-reactive memory T cells (TC) that
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= d1(B0 −B1)− f(a)μEbVEB1 − f(a)μBbVBB1
dB2
dt
= ρ(f(a)μEbVEB1 + f(a)μBbVBB1)− (d2 + c)B2 − k2B2T2 − χ2k2B2T2c
dB3
dt
= cB2 + rB3 − srB3
dB4
dt
= rB3 − d4B4 − k4B4T4 − χ4k4B4T4c
dE1
dt
= de(E0 − E1)− h(a)μBeVBE1 − h(a)μEeVEE1
dE4
dt
= h(a)μBeVBE1 + h(a)μEeVEE1 − (de + γ)E4 − k4E4T4 − χ4k4E4T4c (2.1)
dVB
dt
= nd4B4 − dvVB
dVE
dt
= nγE4 − dvVE
dT2
dt






= (1− σ4)φ4TN [w(B4 + E4)] + θ4T4[w(B4 + E4)]− δT4
dT4c
dt
= σ4mφ4TM [w(B4 + E4)] +mθ4T4c[w(B4 + E4)]−mδT4c .
The dynamics of B cells obey these assumptions:
• Naive B cells have an initial population size of B0 and turnover rate d1. They encounter and
are infected by VB and VE with rates f(a)VBμBb and f(a)VEμEb, respectively, where f(a)
represents the inhibiting eﬀect of host saliva and antibody responses on infection of B cells
(Equation 2.3).
• An infection of a naive cell, B1, may give rise to one or more latently infected cells, B2, due to
the limited proliferation of these newly infected cells, where ρ is the proliferation factor. These
B2 cells die at rate d2, and are recognized and killed by speciﬁc or cross-reactive eﬀector T
cells at rate k2 or χ2k2, respectively. They can also enter the latently infected memory state,
driven by EBV turning oﬀ its gene expression, at rate c.
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They are invisible to the immune system, and undergo cell division with rate r, where one cell
goes into lytic infection and one stays in the memory state. The rate sr represents the death
of B3 due to homeostasic regulation of memory cells, where s is the regulation factor. For a
normal homeostasis, s = 2 balances the proliferation rate of 2r (Macallan et al., 2005).
• Lytically infected B cells, B4, arise from lytic reactivation of memory infected B cells at rate
r, die and release viruses at rate d4, and can be killed by speciﬁc or cross-reactive eﬀector T
cells at rate k4 or χ4k4, respectively.
Here, χj (j = 2 or 4), with 0 ≤ χj ≤ 1, characterizes the eﬃciency of cross-reactive T cells in killing
infected cells, compared to speciﬁc T cells. The smaller χj is, the more ineﬃcient cross-reactive T
cells are in killing infected cells.
The dynamics of epithelial cells assume the following:
• Uninfected epithelial cells have initial population size of E0 with turnover rate de. They
encounter and are infected by VB and VE with rates h(a)VBμBe and h(a)VEμEe, respectively.
Here, h(a) represents the enhancement eﬀect of host saliva and antibody responses on infection
of epithelial cells (Equation 2.4).
• Lytically infected epithelial cells, E4, die at natural rate de, die due to virus bursting out
at rate γ, and can be killed by speciﬁc or cross-reactive eﬀector T cells at rate k4 or χ4k4,
respectively.
The eﬀects of host saliva and antibody responses on the infection of the two cell types are
represented by the functions f and h, and included as parameters in the cell-speciﬁc infection terms.
This is based on the observation that host saliva and antibodies to viral glycoproteins interfere with
infection of B cells and enhance infection of epithelial cells (Turk et al., 2006). From limited data in
this in vitro study, we obtain the linear relationship between f and h that can be described in the
following equation:
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where λ ≈ 32. The functions f and h carry no units. Without the antibody eﬀect, f = 1 and h = 1.
With antibody eﬀects, f decreases to represent decreased eﬃciency in infection of B cells and h
increases to represent increased eﬃciency in infection of epithelial cells. To model the dependence
of f and h on antibody response, we assume that the two functions take on the forms








where a represents the strength of saliva and antibody eﬀects. We will refer to a as the antibody
eﬀect from now on because the factor(s) in saliva that can enhance infection of epithelial cells remain
unknown. The functions f(a) and h(a) take the form of Hill functions, where λ is the maximum level
of the antibody eﬀect on the infection of epithelial cells and A is the level of a where the eﬀect on
the infection of B cells and epithelial cells is half maximal. As a increases, f(a) decreases while h(a)
increases before saturating. This saturating form assumes that a certain level of antibody response
is required to have strong eﬀects on the infection of both cell types.
Free viruses, VB and VE , are produced from B cells and epithelial cells at rates nd4 and nγ,
respectively, where n is the average burst size. These viruses die at rate dv. To model the CTL
response, we separate the speciﬁc responses against latent (T2) and lytic (T4) infection coming from
naive T cells and the cross-reactive responses (T2c and T4c) coming from the memory T cells speciﬁc
to other encountered pathogens.
We assume that the naive and memory populations, TN and TM , are ﬁxed at constant levels.
Upon stimulation by viral antigens, TN become eﬀector cells against latent or lytic infection at rate
(1−σ2)φ2 or (1−σ4)φ4, respectively, where σj is the fraction of cross-reactive T-cell response. With
further stimulation by viral antigens from infected cells, the activated eﬀector cells, T2 and T4, can
proliferate with rates θ2 and θ4, respectively. Each type of eﬀector cell dies at a similar rate δ.
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where K is the number of infected cells at which activation or proliferation is half maximal and is
assumed to be the same for both responses.
Cross-reactive responses, T2c and T4c, are activated from the memory population at rate σjmφj ,
where m ≥ 1 is a measurement of how much faster a response can be activated from memory T
cells compared to activation from naive T cells. These cross-reactive memory cells are assumed to
have faster dynamics than speciﬁc T cells. Although they may be activated quickly and proliferate
rapidly, they die faster (by a factor m). This comes from observations that memory cells respond
with fast kinetics (Kedl and Mescher, 1998), but are also more susceptible to death (Cerwenka
et al., 1999). Furthermore, T cells obtained from acute IM patients have been shown to have high
expression of programmed-death-1 (Hislop et al., 2007).
The system Equation (2.1) has two equilibria: an infection-free equilibrium and a persistent
equilibrium. The infection-free equilibrium is given by
B∗1 = B0 , E
∗
1 = E0 ,
with other state variables equal zero. The stability of the infection-free equilibrium is determined





















(s− 1)(d2 + c)(de + γ) . (2.6)
Infections of both B cells and epithelial cells contribute to the basic reproductive ratio of EBV. The
antibody eﬀects, f(a) and h(a), shift the weight of R0 contribution from B cells to epithelial cells.
If R0 < 1, the infection-free equilibrium is stable and the infection cannot establish within a host.
If R0 > 1, the infection-free equilibrium is unstable and EBV can establish a persistent infection,
where all state variables take on positive values. Tables 1 and 2 present the parameter values used
for simulations and analysis of the model.
Assuming no cross-reactive responses (σ2, σ4 = 0), the dynamics of viruses and T cells for the
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Table 1: Parameters for the dynamics of B cells and antibody eﬀect used in the model simulations
(Equation 2.1). We use many parameters from PathSim, where the rates are estimated and given
in a unit of per 6 minutes (Shapiro et al., 2008), and convert them into the unit of per minute.
Parameter Description Value Value Reference
d1 Turnover rate of naive B cells 1/6000 min−1 (Shapiro et al., 2008)
μEb B cell infection rate per 3.3× 10−10 min−1virus−1 (Shapiro et al., 2008) 1
epithelial-cell virus
μBb B cell infection rate per μEb/100 min
−1virus−1 (Hutt-Fletcher, 2005)
B-cell virus
ρ Proliferation factor 2 no unit (Shapiro et al., 2008)
d2 Death rate of latently infected 1/11520 min−1 (Shapiro et al., 2008)
B cells
c Rate of latently infected cells 0.001 min−1 (Shapiro et al., 2008) 2
going into memory stage
k2 Rate of latently infected 3.8× 10−8 min−1cell−1 (Shapiro et al., 2008) 3
B cells killed by T cells
r Rate of reactivation of lytic 8.3× 10−5 min−1 (Shapiro et al., 2008)
infection from latent infection
s Regulation factor of 2 no unit (Macallan et al., 2005)
memory B cells
d4 Death rate of lytically infected 1/4320 min−1 (Shapiro et al., 2008)
cells due to viruses bursting out
k4 Rate of lytically infected 7.6× 10−8 min−1cell−1 (Shapiro et al., 2008)3
B cells killed by T cells
a The strength of antibody eﬀect variable (0-40) no unit
A Level of a where antibody eﬀect 10 no unit
is half maximal
λ Maximal level of antibody eﬀect 32 no unit (Turk et al., 2006)4
on epithelial cell infection
1Probability of virus and cell encounter per minute multiplied by probability of infection and
divided by the number of viruses (≈ 107)
2We take this to be the same rate as the estimation of .1% of lymphocytes leaving
the Waldeyer’s ring per minute
3Probability of lymphocyte encounter per minute multiplied by the probability that Ti kills its
target and divided by the number of Ti(≈ 104)
4Estimated from limited data given in an in vitro study (Borza and Hutt-Fletcher, 2002)
and 2(ii), respectively. The antibody eﬀect greatly increases the number of viruses being produced,
with most of this increase coming from epithelial-cell viruses. Elevated number of T cells against
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Table 2: Parameters for the dynamics of epithelial cells, virus, and T-cell responses used in the
model simulations (Equation 2.1).
Parameter Description Value Unit Reference
de Turn-over rate of epithelial cells 1/6000 min−1 1
μBe Epithelial cell infection rate 3× 10−11 min−1virus−1 2
per B-cell virus
μEe Epithelial cell infection rate μBe/5 min
−1virus−1 (Hutt-Fletcher, 2005)
per epithelial-cell virus
γ Death rate of infected epithelial 1/6000 min−1
cells due to viruses bursting out 3
n Viral burst size 1000 virus·cell−1 (Shapiro et al., 2008)
dv Death rate of virus 1/2160 min−1 (Shapiro et al., 2008)
σj Fraction of eﬀector cells activated variable (0-1) no unit
from cross-reactive memory T cells
m Factor of faster response 5 no unit (Kedl and Mescher, 1998)
from memory T cells
φ2 Rate of T cell activation 1.95× 10−5 min−1 (Shapiro et al., 2008)4
against latent infection
φ4 Rate of T cell activation 4.48× 10−5 min−1 (Shapiro et al., 2008)4
against lytic infection
θ2 Rate of T cell proliferation 3.25× 10−5 min−1 (Shapiro et al., 2008)5
against latent infection
θ4 Rate of T cell proliferation 3.25× 10−5 min−1 (Shapiro et al., 2008)5
against lytic infection
K Number of infected cells when 105 cell (Jones and Perelson, 2005)
T cell activation is half maximal
δ Death rate of T cells 1/156000 min−1 (Shapiro et al., 2008)
1Estimated, taken to be the same as d1
2Estimated, taken to be less than μEb (Turk et al., 2006)
3Estimated, taken to be less than d4 (Borza and Hutt-Fletcher, 2002)
4Probability of lymphocyte encounter per minute multiplied by the probability of Ti activation
by Bi, where i = 2 or 4
5Probability of lymphocyte encounter per minute multiplied by the frequency of cell division
(every 8-12 hours)
3 Application to infectious mononucleosis
EBV infection in children of young age is usually asymptomatic. Adolescents and young adults
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σj = 0, a = 10
 
 























Figure 2: Dynamics of viruses and T cells in the case of no cross-reactive T-cell responses (σj = 0).
(i) Without antibody eﬀect (a = 0). (ii) With antibody eﬀect (a = 10). The insets show the level
of persistent virus for the two cases. Parameter values used are shown in Tables 1 and 2.
These symptoms result from a massive T-cell response to EBV a few weeks after the initial viral
infection that can last from a few weeks to several months (Cohen, 2005). The T-cell responses
against viral latent proteins are generally smaller in magnitude than the T-cell responses against
viral lytic proteins during the acute phase of IM. The acute phase is followed by convalescence and
eventually a virus carrier state where the CD8+ population resolves to a level comparable to that
in asymptomatic carriers (Hislop et al., 2007).
We use numerical solutions of our model to investigate the three hypotheses for the high preva-
lence of IM in teenagers and young adults: saliva and antibody eﬀects, cross-reactive T-cell responses,
and the initial viral load. The total number of T cells (both speciﬁc and cross-reactive ones) and
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T cell ratio is the ratio between eﬀector T cells responding against lytic infection and eﬀector T
cells responding against latent infection, (T4 + T4C)/(T2 + T2C). A wide range of values of these
two measurements has been observed in IM patients. Individual epitope responses against latent
and lytic infections can account for 0.1%-5% and 1%-40% of the total CD8+ T cell population,
respectively (Hislop et al., 2007).
3.1 Antibody eﬀects
Race, sex, and age are at least in part responsible for individual diﬀerences in antibody responses
(Buckley and Dorsey, 1971; Childers et al., 2003; Jafarzadeh et al., 2008), which may inﬂuence the
outcomes of EBV infection. Titers of antibody responses speciﬁc to EBV viral capsid antigen, IgA
and IgG, have been observed to increase with age and IgA attains its highest level during the onset
of disease within IM patients (Edwards and Woodroof, 1979; Oberender et al., 1986). Furthermore,
individuals are exposed to more pathogens as they age. EBV infection in young adults may activate
antibody responses that are speciﬁc to other viruses, but cross-reactive to EBV. As IgG and IgA
responses to EBV glycoproteins can enhance the lytic infection of epithelial cells, the probability of
getting IM may increase with age.
To examine this hypothesis with our model, we vary the strength of the antibody eﬀect (a) and
study its inﬂuence on the total number of T cells and the lytic T cell ratio (Figure 3) measured at
the peak of infection. The total number of T cells increases with the level of a, but then decreases
when a is large. At high levels of antibody response, infection of B cells is strongly suppressed while
the eﬀect on enhancement of lytic infection of epithelial cells saturates, leading to a decreased total
number of T cells (Figure 3(i)) and increased lytic T cell ratio (Figure 3(ii)).
3.2 Cross-reactive T-cell responses
Massive expansion of CD8+ T cells responding to EBV causes the symptoms of IM (Silins et al.,
2001). It has been proposed that the high susceptibility of teenagers and young adults to IM may
be due to a more complex memory CD8 repertoire than in young children. As individuals age, the
memory CD8 repertoire gets more complex due to exposure to diﬀerent pathogens. Adolescents
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Figure 3: Antibody eﬀects on the total number of T cells (T2 + T2c + T4 + T4c) and the lytic T cell
ratio ((T4 + T4c)/(T2 + T2c)) in the absence of cross-reactive T cells (σj = 0). (i) Total number
of CD8+ T cells at the peak of infection. (ii) The lytic T cell ratio at peak: ratio between the
number of T cells against lytic infection (T4) and the number of T cells against latent infection (T2),
evaluated at the peak of infection. Parameter values are shown in Tables 1, and 2.
in response to other viral infections (Rickinson and Kieﬀ, 1996). In fact, it has been shown that
memory CD8+ T cells speciﬁc to inﬂuenza virus can be activated and respond to stimulation by EBV
lytic proteins (Clute et al., 2005). Both the magnitude and the eﬃciency of cross-reactive T cells in
killing infected cells may contribute to the etiology of IM. The level of cross-reactive memory T cell
can increase with age. These memory cells may be faster at activation and proliferation compared
to naive T cells (Veiga-Fernandes et al., 2000), but less eﬃcient in controlling the infection (Thorley-
Lawson, 2005).
A large fraction of CD8+ T cells created during the course of IM respond to lytic infection (5-
50%, compared to 1-3% for T cells responding to latent infection) (Callan et al., 1998; Hislop et al.,
2002). Since EBV has many more lytic genes than latent genes (Robertson, 2005), it is likely that
there are more cross-reactive T cells to EBV lytic infection than to latent infection. We ﬁrst assume
cross-reaction of only T-cell responses against lytic infection. To address this assumption with our
model, we set σ2 = 0 and consider ﬁve diﬀerent values of σ4, 0, 0.3, 0.6, 0.8, and 1. As σ4 increases,
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there is no speciﬁc lytic T-cell response; all lytic T cells are cross-reactive.
To facilitate comparison with the antibody eﬀect (Figure 3), we present the eﬀects of cross-
reactive T cells on the development of IM using similar plots, with ﬁve curves in each representing
diﬀerent values of the level of cross-reactive lytic T cells (σ4) (Figure 4). This ﬁgure also illustrates
the impact of χ4, the eﬃciency of cross-reactive T cells in killing lytically infected cells, on the two
measurements of IM. Across all levels of antibody eﬀects (a), the increase in σ4 greatly elevates the
total number of T cells and the lytic T cell ratio. This eﬀect, however, diminishes as χ4 increases.
At χ4 = 1, cross-reactive lytic T cells are as eﬃcient as speciﬁc T cells in killing infected cells. In
fact, due to their faster response, cross-reactive T cells reduce the overall T-cell responses and the
probability of IM.
We now add the possibility of cross-reactive T-cell responses against latent infection. Figure 5
shows the eﬀects of this addition on the two measurements of IM. For each level of σ4, we set
σ2 = 0.2σ4, to assume lower levels of cross-reactive T cells against latent infection, compared to
lytic infection. We analyzed and observed only minimal impacts of variation in the eﬃciency of
cross-reactive T cells in killing latently infected cells (χ2), on the results. We thus, ﬁx χ2 = 0.5 for
this analysis. In comparison to the results presented in Figure 4(i), addition of cross-reactive T cells
to latent infection does not induce visible eﬀect on the total number of T cells while the lytic T cell
ratios are signiﬁcantly reduced. This implies that cross-reactive T-cell responses to latent infection
do not induce the high lytic ratio observed in IM patients.
3.3 High initial viral load
A third hypothesis suggests that transmission often occurs through kissing in adolescents which may
transmit a large number of viruses and hence lead to aggressive CD8+ T-cell responses. To analyze
this hypothesis, we numerically solve Equation (2.1) with ﬁve diﬀerent levels of the initial viral load,
V0. In comparison to antibody and cross-reactive T-cell eﬀects, the initial viral load has very little










anuscript          
University of Utah Institutional Repository  
Author Manuscript 
(i) (ii)





















































strength of antibody effect (a)
























































strength of antibody effect (a)
Figure 4: The eﬀects of cross reactive T-cell responses to viral lytic proteins (σ4 > 0) on the total
number of T cells and the lytic T cell ratio during primary infection as a function of the strength
of the antibody eﬀect (a). The ﬁve diﬀerent degrees of cross-reactive responses are shown in each
plot. (i) Left column: low eﬃciency of cross-reactive lytic T cells in killing infected cells (χ4 = 0.1).
(ii) Right column: cross-reactive T cells are as eﬃcient as speciﬁc T cells in killing infected cells
(χ4 = 1). Other parameter values are shown in Tables 1, and 2.
3.4 Combined eﬀects of antibody and cross-reactive T-cell responses
So far, our model supports the roles of antibody eﬀects and the cross-reactive T cells in the devel-
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strength of antibody effect (a)
Figure 5: The eﬀects of both latent and lytic cross reactive T cells (σj > 0) on the total number
of T cells and the lytic T cell ratio during primary infection as a function of the strength of the
antibody eﬀect (a). The ﬁve diﬀerent degrees of cross-reactive responses are shown in the plots. For
each level of σ4, σ2 = 0.2σ4. We set χ2 = 0.5 and χ4 = 0.1. Other parameter values are shown in
Tables 1, and 2.


















































strength of antibody effect (a)
Figure 6: The eﬀect of initial viral load (V0) on the total number of T cells and the lytic T cell ratio
during primary infection as a function of the strength of the antibody eﬀect (a). We set σj = 0,
which represents no cross-reactive T cell response. Other parameter values are shown in Tables 1,
and 2.
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The relative total T cell number gives the ratio between the total number of T cells given values of
σj and a and the one with a baseline σj = 0 and a = 0,
(T2 + T4 + T2C + T4C)
(T2 + T4 + T2C + T4C)σj=0,a=0
.
We examine ﬁve diﬀerent levels of cross-reactive T cells to lytic infection (σ4), four diﬀerent levels
of cross-reactive T cell against latent infection (σ2), ﬁve diﬀerent levels of the eﬃciency of lytic T
cells in killing infected cells (χ4), and ﬁx χ2 = 0.5 (Figure 7).
Infectious mononucleosis (IM) is assumed to be possible when both ratios, the relative total T
cell number and the relative lytic T cell ratio are large (≥ 5). Studies give a wide range for these
ratios (Callan et al., 1998; Hislop et al., 2002; Silins et al., 2001), so these threshold levels of ≥ 5 are
not to be conclusive. In the absence of antibody eﬀects (a = 0), IM can only be explained with very
high levels of cross-reactive lytic T cells together with a low eﬃciency of these cells in killing infected
cells. In the absence of cross-reactive T cells (σj = 0, a > 0), antibody eﬀects induce increases in
the total number of T cells and the lytic T cell ratio. However, these increases are not as signiﬁcant
as those induced by the combined eﬀects of antibodies with cross-reactive T cells. Thus, IM is
characterized by high level of antibody eﬀects, high level of cross-reactive T cells to lytic infection,
and low eﬃciency of cross-reactive T cell in killing infected cells. As individuals age, the levels of
antibody eﬀects and the cross-reactive T cells increase; hence, the probability of IM increases if the
cross-reactive T cells do not eﬃciently kill infected cells.
4 Discussion
Infectious mononucleosis (IM) is characterized by a large T-cell response, primarily to the lytic
phase of the infection and thus can result from two broad changes in the course of acute infection.
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σ4 = 0.3, 0.6, 0.8, 1; σ2 = σ4/5






◦ ◦ σ4 = 0.3, 0.6, 0.8, 1; σ2 = σ4
σj = 0, a > 0







n a:: σj = 0, a = 0
Figure 7: Combined eﬀects of antibodies with cross-reactive T cells on the relative T cell number and
the relative lytic T cell ratio. (i) a = 0. (ii) a = 4. (iii) a = 10. (iv) a = 30. The green lines show the
area of possible IM cases with high levels of the relative total T cell number and the relative lytic T
cell ratio (≥ 5). Four diﬀerent colors (symbols) represents diﬀerent levels of cross-reactive latent T
cells (σ2). Symbol size represents diﬀerent levels of cross-reactive lytic T cells (σ4 = 0.3, 0.6, 0.8, 1).
The label numbers next to the symbol represent the eﬃciency of lytic T cells in killing infected cells
(χ4). We examine ﬁve diﬀerent levels of χ4 (0.1, 0.2, 0.5, 0.7, 1) and only label the points of possible
IM cases. The characters n and a represent the normal condition (σj = 0, a = 0) and the conditions
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alternates between infecting B cells (its primary target), with either latent or lytic infection, and
epithelial cells (important in viral persistence and shedding), as lytic infection only. Any factor that
biasses infection toward epithelial cells can increase the importance of lytic infection and potentially
increase the probability of IM. Switching between B-cell and epithelial-cell virus is modulated by
antibody responses and unknown constituents in the saliva (Turk et al., 2006). Hosts with increased
IgA antibodies may be prone to large expansions of T cell against viral lytic proteins. Second, a host
could have a less eﬃcient T-cell response against the virus. EBV infection can activate cross-reactive
memory T cells that are speciﬁc to other pathogens (Clute et al., 2005). If these cells are activated
in large number, but recognize and kill target cells ineﬃciently, IM may result. The high initial viral
load hypothesis cannot produce large expansions of T cells and thus cannot be used to explain the
age dependence of IM.
In economically developed countries, IM has highest incidence in the 15- to 25-year-old age group.
In developing countries like Brazil, the age distribution of IM is shifted downward with mean age of
IM around 13 years (Niederman and Evans, 1997). If people in developing countries are exposed to
more diseases at an earlier age, they could have both higher antibody level and a larger pre-existing
memory CD8 repertoire compared to age matched counterparts from developed countries. Together,
these eﬀects may explain the diﬀerence in age distribution of IM.
We built the component of antibody eﬀects in our model based on an in vitro study of the host
saliva and antibody eﬀects on the infections of B cells and epithelial cells with limited data from
saliva samples of infected and uninfected individuals (Turk et al., 2006). The goal of our study was
not to predict the exact level of antibodies that induces large expansion of T cells and symptoms
of IM, but to identify the potential risks in their eﬀects. Our model highlights a need for further
studies on the constituents of the saliva inﬂuencing infection of the two cell types, and studies to
compare the levels of antibodies, especially IgA, to EBV viral capsid antigens and glycoproteins
during the acute phase of infection between asymptomatic and symptomatic patients. These studies
would help to identify the existence of thresholds of antibody levels or other factors in the host saliva
that direct the course of infection.
We have used our model to show that both the magnitude and the quality of T cells in killing the
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that large expansion of CD8+ T cells occur only when they are ineﬃcient at killing. A study on
mice shown that infection with lymphocytic choriomeningitis virus (LCMV), Pichinde virus (PV), or
vaccinia virus (VV) can activate cross-reactive T cells that are speciﬁc to one of these viruses (Selin
et al., 1998). These cross-reactive responses are fast, functionally eﬃcient, and hence help to clear
the secondary virus infection. Study of T-cell responses to dengue virus has shown that diﬀerent
cross-reactive T cell clones can have very diﬀerent eﬃciencies in recognizing and killing the infected
cells (Imrie et al., 2007). In vitro study has shown that EBV antigen can activate cross-reactive T
cells that are speciﬁc to inﬂuenza-A virus, but the killing eﬃciency of these cells has not yet been
determined (Clute et al., 2005). As the pre-existing memory CD8 repertoire evolves with age, we do
not know how the functional eﬃciency of these memory cells changes. Further studies to compare
the recognizing and killing eﬃciency of eﬀector T cells during primary infection of EBV between
diﬀerent age groups, and between healthy and IM patients, are needed to address this question and
to validate the results of our model.
Studies have also suggested that genetic factors can contribute to diﬀerences in eﬃciency of T-cell
responses to EBV, which implies diﬀerence in susceptibility to IM between individuals (McAulay
et al., 2007). Individuals with certain HLA class I alleles are linked to higher risk of IM. HLA
class I plays a key role in the process of antigen presentation by infected cells to T cells (Farrell,
2007). Hence, a diﬀerence in HLA alleles can induce diﬀerent rates at which T cells can be activated,
proliferate, recognize, and kill infected cells. Similar to the way we model the cross-reactive T-cell
responses, we can utilize our model to address this hypothesis on the genetic predisposition to IM.
Even though infectious mononucleosis is rarely lethal, it may induce long-term eﬀects on the
population of T cells (Sauce et al., 2006; Hislop et al., 2007). Infectious mononucleosis is strongly
correlated with increased risk of EBV-positive Hodgkin’s lymphoma in the years after infection
(Hjalgrim et al., 2003). Understanding risk factors for IM may help to investigate the long-term
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